Bio News
Targeting GPX1 inhibited tumor growth, highlighting potential for new anticancer drug development
A new GPX1-OSBPL8 signaling axis that prevents the natural death of cancer cells has been identified as a ‘brake.’ Under oxidative stress, OSBPL8 recruits GPX1, which prevents lipid peroxidation and suppresses cell death. GPX1, which is overexpressed in at least three types of cancer, including pancreatic cancer, has emerged as a new target for anticancer drug development.
Biobook Team
biobookmedia@biobook.co.krMerck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
